Resverlogix announced apabetalone treatment prior to SARS-CoV-2 exposure reduced viral infection
On Dec. 22, 2020, Resverlogix announced published findings in the Proceedings of the National Academy of Sciences (PNAS),…
On Dec. 22, 2020, Resverlogix announced published findings in the Proceedings of the National Academy of Sciences (PNAS),…
On Dec. 22, 2020, the NIH researchers announced they had isolated a set of promising, tiny antibodies, or…
On Dec. 22, 2020, the NIH researchers announced that three clinical trial platforms working together to test the…
On Dec. 22, 2020, Sorrento Therapeutics announced that an Emergency Use Authorization (EUA) Application had been submitted to…
On Dec. 22, 2020, Abivax announced that the Companyï¾’s ongoing ABX464 phase 2b/3 trial in high-risk Covid-19 patients…
On Dec. 22, 2020, a phase II clinical trial of a treatment for COVID-19 patients was started at…
On Dec. 22, 2020, RedHill Biopharma announced that the global Phase 2/3 study with orally-administered opaganib (Yeliva, ABC294640)1…
On Dec. 22, 2020, the ACIP updated interim vaccine allocation recommendations. In Phase 1b, COVID-19 vaccine should be…
On Dec. 22, 2020, Cocrystal Pharma announced the selection of CDI-45205 as the lead compound for further development…
On Dec. 1, 2020, the governmenrt of Singapore announced that it had given U.S. start-up Eat Just the…
On Dec. 21, 2020, CureVac announced that the first participant in a clinical Phase 3 study with its…
On Dec. 21, 2020, CVS Health announced it had formally launched its COVID-19 vaccination program for long-term care…
On Dec. 21, 2020, the NIH announced that it had awarded over $107 million to support new, non-traditional…
On Dec. 21, 2020, the NIH announced that it had awarded eight research grants to develop approaches for…
On Dec. 21, 2020, the NIH announced a study published in Proceedings of the National Academy of Sciences…
On Dec. 21, 2020, the WHO reported that authorities of the United Kingdom of Great Britain and Northern…
On Dec. 21, 2020, the U.S. Dept. of Veterans Affairs (VA) announced that it had begun COVID-19 vaccinations…
On Dec. 21, 2020, Aimmune Therapeutics announced that the European Commission (EC) had approved PALFORZIA [defatted powder of…
On Dec. 21, 2020, Quidel announced that it had received Emergency Use Authorization from the FDA to market…
On Dec. 21, 2020, Innovation Pharma announced that the FDA had approved the Companyï¾’s Investigational New Drug (IND)…
On Dec. 21, 2020, Abiomed announced the first two patients in the world had been treated with the…
On Dec. 21, 2020, Innovation Pharmaceuticals announced that the FDA had approved the Companyï¾’s Investigational New Drug (IND)…
On Dec. 21, 2020, LabCorp and Walgreens announced that the Pixel by Labcorpï¾™ At-Home COVID-19 Collection Kit is…
On Dec. 21, 2020, Novan announced it had entered into a Master Services Agreement (MSA) with Catalent, which…
On Dec. 21, 2020, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
On Dec. 21, 2020, Pfizer and BioNTech announced that the European Commission (EC) had granted a conditional marketing…
On Dec. 21, 2020, OraSure Technologies disclosed that the FDA had requested additional information as part of its…
On Dec. 19, 2020, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for use of…
On Dec. 19, 2020, Pfizer and BioNTech announced they supplying an additional 100 million doses of COMIRNATY the…
On Dec. 18, 2020, the FDA approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System,…